Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 26, 2017

DrugPatentWatch Database Preview

DOCETAXEL Drug Profile

« Back to Dashboard

What is the patent landscape for Docetaxel, and what generic alternatives are available?

Docetaxel is a drug marketed by Apotex Inc, Sandoz, Hospira Inc, Eagle Pharms, Actavis Llc, Pfizer Labs, Jiangsu Hengrui Med, Dfb Oncology Ltd, Teva Pharms Usa, Dr Reddys Labs Ltd, and Accord Hlthcare. and is included in eleven NDAs. There are two patents protecting this drug.

This drug has fifteen patent family members in fifteen countries.

The generic ingredient in DOCETAXEL is docetaxel. There are forty drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the docetaxel profile page.

Summary for Tradename: DOCETAXEL

Suppliers / Packagers: see list12
Bulk Api Vendors: see list59
Clinical Trials: see list667
Patent Applications: see list9,845
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DOCETAXEL at DailyMed

Pharmacology for Tradename: DOCETAXEL

Drug ClassMicrotubule Inhibitor
Physiological EffectMicrotubule Inhibition
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
INJECTABLE;INJECTION204193-001Nov 5, 2014APRXNoNo► Subscribe► Subscribe
Dfb Oncology Ltd
INJECTABLE;INJECTION206177-002Jan 20, 2017APRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
INJECTABLE;INJECTION204193-002Nov 5, 2014APRXNoNo► Subscribe► Subscribe
Dfb Oncology Ltd
INJECTABLE;INJECTION206177-003Jan 20, 2017RXNoNo► Subscribe► Subscribe
Apotex Inc
INJECTABLE;INJECTION022312-001Jan 11, 2012DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Formulary management
  • Set up watchlists for daily email updates

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus